Corvus Pharmaceuticals Statistics
NASDAQ: CRVSHealth CareBiotechnology: Pharmaceutical PreparationsUSD
9.67-0.34 (-3.40%)
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Corvus Pharmaceuticals by the numbers
Corvus Pharmaceuticals has a market capitalization of $815.7 million based on 84.35M shares outstanding. With trailing EPS of $-0.72, Corvus Pharmaceuticals is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 10.8% below its 50-day average and 29.6% below its 200-day average.
Average daily trading volume is 1.05M shares, or about $10.1 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
CRVS valuation vs. peer median
| Metric | CRVS | Peer median | Difference |
|---|---|---|---|
| Market cap | $815.69M | $791.36M | +3% |
| Avg. volume | 1.05M | 1.17M | -11% |
Peer median across 8 companies: PHAR, VSTM, SNDX, IRWD, MTRI, LTGO, COLL, ORIC.
Valuation
- Market cap
- $815.69M
- EPS (TTM)
- $-0.72
- Shares outstanding
- 84.35M
Price and trading
- Previous close
- 10.01
- Open
- 9.84
- Day range
- 9.56 – 10.03
- 52-week range
- 6.39 – 26.95
- 52-week change
- +12.84%
- Beta
- —
- Volume
- 927.52K
- Average volume
- 1.05M
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 5, 2026
Additional statistics
- Market Cap
- 815.69M
- Forward Pe
- -8.79
- Eps
- -0.72
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 26.95
- Week52 Low
- 6.39
- Avg Volume
- 1.05M
- Shares Outstanding
- 84.35M
- Ma50
- 10.84
- Ma200
- 13.73
- Earnings Date
- Nov 5, 2026
- Pct From52w High
- -64.12%
- Pct From52w Low
- 51.33%